QQQ   438.50 (+0.05%)
AAPL   175.01 (-0.87%)
MSFT   422.54 (+0.15%)
META   509.12 (-0.54%)
GOOGL   158.24 (+0.32%)
AMZN   187.02 (+0.48%)
TSLA   165.33 (-3.34%)
NVDA   888.84 (+0.79%)
AMD   162.29 (-0.61%)
NIO   3.95 (-3.89%)
BABA   71.29 (+0.00%)
T   16.31 (+0.00%)
F   12.46 (-1.19%)
MU   123.58 (+0.87%)
GE   155.36 (+0.47%)
CGC   7.30 (-6.41%)
DIS   114.09 (+0.07%)
AMC   2.63 (-0.75%)
PFE   26.00 (+0.54%)
PYPL   64.69 (+0.15%)
XOM   120.60 (+0.19%)
QQQ   438.50 (+0.05%)
AAPL   175.01 (-0.87%)
MSFT   422.54 (+0.15%)
META   509.12 (-0.54%)
GOOGL   158.24 (+0.32%)
AMZN   187.02 (+0.48%)
TSLA   165.33 (-3.34%)
NVDA   888.84 (+0.79%)
AMD   162.29 (-0.61%)
NIO   3.95 (-3.89%)
BABA   71.29 (+0.00%)
T   16.31 (+0.00%)
F   12.46 (-1.19%)
MU   123.58 (+0.87%)
GE   155.36 (+0.47%)
CGC   7.30 (-6.41%)
DIS   114.09 (+0.07%)
AMC   2.63 (-0.75%)
PFE   26.00 (+0.54%)
PYPL   64.69 (+0.15%)
XOM   120.60 (+0.19%)
QQQ   438.50 (+0.05%)
AAPL   175.01 (-0.87%)
MSFT   422.54 (+0.15%)
META   509.12 (-0.54%)
GOOGL   158.24 (+0.32%)
AMZN   187.02 (+0.48%)
TSLA   165.33 (-3.34%)
NVDA   888.84 (+0.79%)
AMD   162.29 (-0.61%)
NIO   3.95 (-3.89%)
BABA   71.29 (+0.00%)
T   16.31 (+0.00%)
F   12.46 (-1.19%)
MU   123.58 (+0.87%)
GE   155.36 (+0.47%)
CGC   7.30 (-6.41%)
DIS   114.09 (+0.07%)
AMC   2.63 (-0.75%)
PFE   26.00 (+0.54%)
PYPL   64.69 (+0.15%)
XOM   120.60 (+0.19%)
QQQ   438.50 (+0.05%)
AAPL   175.01 (-0.87%)
MSFT   422.54 (+0.15%)
META   509.12 (-0.54%)
GOOGL   158.24 (+0.32%)
AMZN   187.02 (+0.48%)
TSLA   165.33 (-3.34%)
NVDA   888.84 (+0.79%)
AMD   162.29 (-0.61%)
NIO   3.95 (-3.89%)
BABA   71.29 (+0.00%)
T   16.31 (+0.00%)
F   12.46 (-1.19%)
MU   123.58 (+0.87%)
GE   155.36 (+0.47%)
CGC   7.30 (-6.41%)
DIS   114.09 (+0.07%)
AMC   2.63 (-0.75%)
PFE   26.00 (+0.54%)
PYPL   64.69 (+0.15%)
XOM   120.60 (+0.19%)

Genetic Technologies (GENE) Competitors

$3.28
-0.04 (-1.20%)
(As of 10:54 AM ET)

GENE vs. ONVO, BCDA, COEP, CHRO, CELZ, IKT, TTNP, FRTX, EVAX, and SNTI

Should you be buying Genetic Technologies stock or one of its competitors? The main competitors of Genetic Technologies include Organovo (ONVO), BioCardia (BCDA), Coeptis Therapeutics (COEP), Chromocell Therapeutics (CHRO), Creative Medical Technology (CELZ), Inhibikase Therapeutics (IKT), Titan Pharmaceuticals (TTNP), Fresh Tracks Therapeutics (FRTX), Evaxion Biotech A/S (EVAX), and Senti Biosciences (SNTI). These companies are all part of the "biological products, except diagnostic" industry.

Genetic Technologies vs.

Genetic Technologies (NASDAQ:GENE) and Organovo (NASDAQ:ONVO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.

0.6% of Genetic Technologies shares are owned by institutional investors. Comparatively, 8.2% of Organovo shares are owned by institutional investors. 6.5% of Genetic Technologies shares are owned by insiders. Comparatively, 5.0% of Organovo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Genetic Technologies and Genetic Technologies both had 4 articles in the media. Organovo's average media sentiment score of 0.94 beat Genetic Technologies' score of 0.51 indicating that Organovo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genetic Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Organovo
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Genetic Technologies has higher revenue and earnings than Organovo.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genetic Technologies$5.85M2.16-$7.91MN/AN/A
Organovo$370K36.63-$17.26M-$2.17-0.62

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genetic Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Organovo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Genetic Technologies has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Organovo has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500.

Genetic Technologies' return on equity of 0.00% beat Organovo's return on equity.

Company Net Margins Return on Equity Return on Assets
Genetic TechnologiesN/A N/A N/A
Organovo N/A -182.88%-138.52%

Organovo received 35 more outperform votes than Genetic Technologies when rated by MarketBeat users. However, 55.33% of users gave Genetic Technologies an outperform vote while only 50.91% of users gave Organovo an outperform vote.

CompanyUnderperformOutperform
Genetic TechnologiesOutperform Votes
161
55.33%
Underperform Votes
130
44.67%
OrganovoOutperform Votes
196
50.91%
Underperform Votes
189
49.09%

Summary

Genetic Technologies beats Organovo on 7 of the 11 factors compared between the two stocks.

Get Genetic Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GENE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GENE vs. The Competition

MetricGenetic TechnologiesBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$12.63M$2.60B$4.64B$7.64B
Dividend YieldN/A2.27%5.44%3.95%
P/E RatioN/A16.78166.9614.24
Price / Sales2.16331.682,392.5191.07
Price / CashN/A134.3932.7328.16
Price / Book1.683.974.774.58
Net Income-$7.91M-$46.07M$97.42M$209.42M
7 Day Performance14.69%-0.45%108.95%-1.19%
1 Month Performance21.93%0.55%114.41%3.41%
1 Year Performance-40.36%27.47%137.54%9.19%

Genetic Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONVO
Organovo
0.7427 of 5 stars
$1.03
flat
N/A-52.6%$10.34M$370,000.00-0.4718News Coverage
Gap Up
BCDA
BioCardia
2.7827 of 5 stars
$0.40
flat
$4.00
+900.8%
-80.1%$10.68M$480,000.00-0.7330Positive News
Gap Up
COEP
Coeptis Therapeutics
1.6651 of 5 stars
$0.31
+6.8%
$4.33
+1,277.0%
-68.0%$11.36M$80,000.00-0.374Positive News
Gap Up
High Trading Volume
CHRO
Chromocell Therapeutics
0 of 5 stars
$2.40
+0.4%
N/AN/A$9.31MN/A0.003
CELZ
Creative Medical Technology
1.0754 of 5 stars
$5.62
+1.1%
N/A-26.5%$7.64M$10,000.00-1.514Short Interest ↓
IKT
Inhibikase Therapeutics
1.0514 of 5 stars
$2.15
-0.5%
$27.00
+1,155.8%
-36.7%$13.93M$260,000.00-0.606Gap Down
TTNP
Titan Pharmaceuticals
0 of 5 stars
$7.18
+3.2%
N/A-54.1%$5.39M$560,000.000.004Analyst Report
News Coverage
Gap Up
FRTX
Fresh Tracks Therapeutics
0 of 5 stars
$0.89
-1.1%
N/A+48.2%$5.31M$8.01M-0.6313
EVAX
Evaxion Biotech A/S
2.518 of 5 stars
$3.88
+20.1%
$14.00
+260.8%
-73.7%$15.71M$70,000.00-0.5763Gap Down
SNTI
Senti Biosciences
2.6319 of 5 stars
$0.35
-5.4%
$6.00
+1,619.2%
-68.4%$15.97M$2.56M-0.2248Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:GENE) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners